Edition:
United States

Active Biotech AB (ACTI.ST)

ACTI.ST on Stockholm Stock Exchange

11.60SEK
22 Jul 2016
Change (% chg)

0.10kr (+0.87%)
Prev Close
11.50kr
Open
11.40kr
Day's High
11.65kr
Day's Low
11.40kr
Volume
15,702
Avg. Vol
55,616
52-wk High
17.30kr
52-wk Low
7.50kr

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -- December 22 Jul 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 0 0 0 0
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 3.00 3.00 3.00 3.00

Consensus Estimates Analysis

Sales and Profit Figures in Swedish Krona (SEK)
Earnings and Dividend Figures in Swedish Krona (SEK)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Dec-16 1 16.00 16.00 16.00 53.59
Year Ending Dec-17 1 392.00 392.00 392.00 299.48
Earnings (per share)
Year Ending Dec-16 1 -0.02 -0.02 -0.02 -0.60

Historical Surprises

Sales and Profit Figures in Swedish Krona (SEK)
Earnings and Dividend Figures in Swedish Krona (SEK)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-15 3.12 5.20 2.08 66.67
Quarter Ending Dec-14 2.75 2.90 0.15 5.45
Quarter Ending Sep-14 2.80 2.60 0.20 7.14
Quarter Ending Jun-14 3.00 2.70 0.30 10.00
Quarter Ending Dec-13 93.00 4.00 89.00 95.70
Earnings (per share)
Quarter Ending Sep-15 -0.74 -0.26 0.48 -64.86
Quarter Ending Dec-14 -0.57 -0.73 0.16 -28.88
Quarter Ending Sep-14 -0.66 -0.72 0.06 -8.57
Quarter Ending Jun-14 -0.85 -0.73 0.12 -14.45
Quarter Ending Sep-13 -0.57 -0.92 0.35 -61.65

Consensus Estimates Trend

Sales and Profit Figures in Swedish Krona (SEK)
Earnings and Dividend Figures in Swedish Krona (SEK)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Dec-16 16.00 16.00 16.00 16.00 53.59
Year Ending Dec-17 392.00 392.00 392.00 392.00 299.48
Earnings (per share)
Year Ending Dec-16 -0.02 -0.02 -0.02 -0.02 -0.60

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0
Earnings
Year Ending Dec-16 0 0 0 0

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Sadif Analytics Prime
$25.00
Provider : Wright Reports
$75.00
Provider : Sadif Analytics Prime
$10.00
Provider : GlobalData
$300.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.